Breast Cancer
📧 Sign up to get email alerts when something new happens for Breast Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-07-08Clinical Trial Results: Diabetes Care for Breast Cancer Patients [NA]
A completed trial evaluating diabetes care in breast cancer patients, including those with prediabetes and type 2 diabetes.
-
CLINICAL_TRIALS trial_result · 2026-07-08Clinical Trial Results: The E-consult Application for Patients With Breast Cancer: Interest in Empathy and Empowerment of Patients.
Completed clinical trial evaluating an e-consult application for patients with breast cancer, focusing on empathy and empowerment.
-
CLINICAL_TRIALS trial_result · 2026-07-07Clinical Trial Results: Trial to Evaluate the Impact of Various Interventions to Increase the Uptake of Surveillance Mammography in Eligible Women in Singapore [NA]
Completed clinical trial evaluating interventions to increase uptake of surveillance mammography among Singaporean women for early breast ca…
-
CLINICAL_TRIALS trial_result · 2026-07-06Clinical Trial Results: Increasing Screening for Cancer Using EHR-Nudges [NA]
Clinical trial results on increasing cancer screening using electronic health record nudges; completed with results posted.
-
CLINICAL_TRIALS trial_result · 2026-07-02Clinical Trial Update: Testing MK-3475 (Pembrolizumab) as Adjuvant Therapy for Triple Receptor-Negative Breast Cancer [Phase 3]
Phase 3 clinical trial update for pembrolizumab as adjuvant therapy in triple-negative breast cancer, status ACTIVE_NOT_RECRUITING.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2026-07-02Clinical Trial Results: Management of Cognitive Difficulties After Cancer Treatments in Women Treated for Breast Cancer: Feasibility Study (Step 1 of the Cog-Stim Protocol) [NA]
A feasibility study (Step 1 of the Cog-Stim Protocol) evaluating management of cognitive difficulties after cancer treatments in women treat…
-
CLINICAL_TRIALS trial_result · 2026-07-02Clinical Trial Results: Use of Cognitive Stimulation Software for Patients Over the Age of 70 Followed for Breast Cancer: COG-TAB-AGE Feasibility Study [NA]
Feasibility study evaluating cognitive stimulation software for patients over 70 with breast cancer; results posted after completion of the …
-
CLINICAL_TRIALS trial_result · 2026-07-02Clinical Trial Results: REduction of Physical Inactivity Facing the CAncer [NA]
Clinical trial results for reducing physical inactivity in patients with breast cancer have been completed; results posted.
-
CLINICAL_TRIALS trial_result · 2026-07-01Clinical Trial Update: Testing MK-3475 (Pembrolizumab) as Adjuvant Therapy for Triple Receptor-Negative Breast Cancer [Phase 3]
Phase 3 trial evaluating pembrolizumab (MK-3475) as adjuvant therapy for triple-negative breast cancer is ongoing with active status.
-
CLINICAL_TRIALS trial_result · 2026-06-26Clinical Trial Results: MRI and Mammography Before Surgery in Patients With Stage I-II Breast Cancer [Phase 3]
Phase 3 trial results comparing MRI and mammography before surgery in stage I-II breast cancer show completed status; results posted.
-
CLINICAL_TRIALS trial_result · 2026-06-25Clinical Trial Results: Study to Assess the Safety of Alpelisib Plus Fulvestrant, in Men and Post-menopausal Women With HR-positive, HER2-negative, Advanced Breast Cancer (aBC) With PIK3CA Mutation, Whose Disease Progressed on or After Endocrine Treatment [Phase 4]
Phase 4 trial evaluating safety of alpelisib plus fulvestrant in men and postmenopausal women with HR-positive, HER2-negative advanced breas…
-
CLINICAL_TRIALS trial_result · 2026-06-25Clinical Trial Update: Testing MK-3475 (Pembrolizumab) as Adjuvant Therapy for Triple Receptor-Negative Breast Cancer [Phase 3]
Phase 3 trial evaluating pembrolizumab (MK-3475) as adjuvant therapy for triple-negative breast cancer; ongoing ACTIVE_NOT_RECRUITING trial …
-
CLINICAL_TRIALS trial_result · 2026-06-22Clinical Trial Results: Effects of Myofascial Massage and Patient-therapist Communication Levels on Shoulder Muscle Properties in Breast Cancer Survivors With Myofascial Pain [NA]
Clinical trial evaluating myofascial massage and patient-therapist communication on shoulder muscle properties in breast cancer survivors wi…
-
CLINICAL_TRIALS trial_result · 2026-06-18Clinical Trial Results: Interest of Virtual Reality on Anxiety Before the Planning CT Scan in Radiotherapy [NA]
Clinical trial results on the use of virtual reality to reduce anxiety before planning CT scans in radiotherapy for cancer patients are post…
-
CLINICAL_TRIALS trial_result · 2026-06-17Clinical Trial Results: Pembrolizumab and Carboplatin in Treating Patients With Circulating Tumor Cells Positive Metastatic Breast Cancer [Phase 2]
Phase 2 trial evaluating pembrolizumab with carboplatin in metastatic breast cancer patients positive for circulating tumor cells; results c…
-
CLINICAL_TRIALS trial_result · 2026-06-17Clinical Trial Update: Testing MK-3475 (Pembrolizumab) as Adjuvant Therapy for Triple Receptor-Negative Breast Cancer [Phase 3]
Phase 3 trial updating pembrolizumab (MK-3475) as adjuvant therapy for triple-negative breast cancer; study status ACTIVE_NOT_RECRUITING.
-
CLINICAL_TRIALS trial_result · 2026-06-15Clinical Trial Results: Pilot Study of an NTproBNP Guided Strategy of Cardioprotection [Phase 1, Phase 2]
Pilot study results explore an NTproBNP-guided strategy to cardioprotection during chemotherapy in patients with cardiotoxicity risks.
-
CLINICAL_TRIALS trial_result · 2026-06-11Clinical Trial Results: Prognostic Impact of the Neutrophil/Lymphocyte Ratio (NLR) in the Treatment of First-line Metastatic or Locally Advanced Breast Cancer Treated With CDK4/6 Inhibitor. [NA]
Clinical trial results examining the prognostic impact of the neutrophil/lymphocyte ratio in first-line metastatic or locally advanced breas…
-
CLINICAL_TRIALS trial_result · 2026-06-10Clinical Trial Results: Treatment Patterns & Clinical Outcomes of Palbociclib Combinations in HR+HER2-MBC
Clinical trial results report on treatment patterns and clinical outcomes of palbociclib combinations in HR+HER2-negative metastatic breast …
-
CLINICAL_TRIALS trial_result · 2026-06-09Clinical Trial Update: Trastuzumab Deruxtecan (T-DXd) Alone or in Sequence With THP, Versus Standard Treatment (ddAC-THP), in HER2-positive Early Breast Cancer [Phase 3]
Phase 3 trial evaluating trastuzumab deruxtecan (T-DXd) alone or in sequence with THP vs standard ddAC-THP in HER2-positive early breast can…
-
CLINICAL_TRIALS trial_result · 2026-06-08Clinical Trial Results: Music Therapy as a Tool for Anxiety Reduction in Localized Breast Cancer [NA]
A completed clinical trial evaluating music therapy for anxiety reduction in breast cancer patients undergoing chemotherapy.
-
CLINICAL_TRIALS trial_result · 2026-06-05Clinical Trial Update: Fulvestrant and/or Anastrozole in Treating Postmenopausal Patients With Stage II-III Breast Cancer Undergoing Surgery [Phase 3]
A Phase 3 clinical trial evaluating fulvestrant and/or anastrozole for postmenopausal patients with stage II-III estrogen receptor-positive,…
-
CLINICAL_TRIALS trial_result · 2026-06-03Clinical Trial Update: Testing MK-3475 (Pembrolizumab) as Adjuvant Therapy for Triple Receptor-Negative Breast Cancer [Phase 3]
Phase 3 trial investigating pembrolizumab (MK-3475) as adjuvant therapy for triple-negative breast cancer; currently active but not recruiti…
-
CLINICAL_TRIALS trial_result · 2026-06-02Clinical Trial Update: Study to Assess the Efficacy and Safety of Alpelisib Plus Fulvestrant in Participants With HR-positive (HR+), HER2-negative, Advanced Breast Cancer After Treatment With a CDK4/6 Inhibitor and an Aromatase Inhibitor. [Phase 3]
A Phase 3 clinical trial evaluating alpelisib plus fulvestrant for HR-positive, HER2-negative advanced breast cancer after CDK4/6 inhibitor …
-
CLINICAL_TRIALS trial_result · 2026-06-02Clinical Trial Update: A Study of DB-1303/BNT323 vs Investigator's Choice Chemotherapy in HER2-Low, Hormone Receptor Positive Metastatic Breast Cancer (DYNASTY-Breast02) [Phase 3]
Phase 3 study evaluating DB-1303/BNT323 versus investigator's choice chemotherapy in HER2-low, hormone receptor–positive metastatic breast c…